` SOPH (Sophia Genetics SA) vs S&P 500 Comparison - Alpha Spread

S
SOPH
vs
S&P 500

Over the past 12 months, SOPH has significantly outperformed S&P 500, delivering a return of +45% compared to the S&P 500's +14% growth.

Stocks Performance
SOPH vs S&P 500

Loading
SOPH
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SOPH vs S&P 500

Loading
SOPH
S&P 500
Difference
www.alphaspread.com

Performance By Year
SOPH vs S&P 500

Loading
SOPH
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sophia Genetics SA vs Peers

S&P 500
SOPH
VEEV
PME
2413
DOCS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sophia Genetics SA
Glance View

Market Cap
316.1m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.36 USD
Overvaluation 8%
Intrinsic Value
Price
S
Back to Top